24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla]
RxNorm concept 2723452, branded drug (sbd). Prescribable name: Otezla XR 75 MG 24HR Extended Release Oral Tablet.
- RxCUI
- 2723452
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2723452 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- apremilast 75 MG (SCDC, consists of)
- apremilast 75 MG [Otezla] (SBDC, consists of)
- {14 (24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla]) / 4 (apremilast 10 MG Oral Tablet [Otezla]) / 4 (apremilast 20 MG Oral Tablet [Otezla]) / 19 (apremilast 30 MG Oral Tablet [Otezla]) } Pack [Otezla 28-Day 10/20/30/75 Starter Pack] (BPCK, contained in)
- Extended Release Oral Tablet (DF, has dose form)
- Otezla (BN, has ingredient)
- 24 HR apremilast 75 MG Extended Release Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 55513051930
- 55513052214
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2723452 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2723452 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2723452. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.